Rockley Photonics is a UK-based startup founded in 2013, focused on developing a disruptive biosensing platform with the potential to transform personal health management and revolutionize healthcare. The company's innovative approach integrates wearable biosensing wristbands, chipsets, and algorithms with cloud-based analytics and AI, enabling non-invasive, continuous, and real-time monitoring of multiple biomarkers. With expertise in silicon photonics, Rockley has achieved a remarkable feat by miniaturizing lab spectrometer capabilities into compact wearable devices and medical monitoring systems, thus enabling the detection and measurement of multiple biomarkers non-invasively in real time. The company's $35.00M post-IPO equity investment in June 2023 underscores investor confidence in its potential to bring about transformative changes in personal health management and healthcare delivery. Rockley's disruptive potential lies in its ability to deliver real-time insights, which could significantly impact how individuals manage their day-to-day health and well-being, as well as drive early detection of diseases. With the promise of empowering consumers to make informed decisions about their health and lifestyle, Rockley Photonics holds substantial promise for investors seeking innovative solutions in the consumer electronics, manufacturing, and semiconductor industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $35.00M | - | 06 Jun 2023 | |
| Post-IPO Debt | $10.00M | 1 |
|
03 Oct 2022 |
| Post-IPO Debt | $81.50M | - | 12 May 2022 | |
| Post-IPO Equity | $150.00M | 3 |
|
12 Aug 2021 |
| Venture Round | $65.00M | 1 | Morningside Venture Investments | 29 Jan 2021 |
No recent news or press coverage available for Rockley Photonics.
We care about your data, and we'd love to use cookies make your experience better.
